Medical marijuana research company reaching for Alzheimers cure
Medical Marijuana Inc. reported this week that studies have shown Cannabidiol, a drug the company is developing, may be useful as a possible prevention and treatment for Alzheimer’s disease. Medical Marijuana Inc. through CannaBANK has a patent pending on an extraction method from Cannabis Sativa (Marijuana) and its industrialized non psychoactive counterpart Hemp, allowing Cannabidiol (CBD) to be isolated in its pure form.
This week’s announcement follows on the heals of last week’s, when the company announced that the same drug had been “proven” to be an anti-cancer and anti-tumor agent.
The company, like so many others today, is racing to isolate various medicinal properties of marijuana from the THC that gets recreational users high.
The small–but fast growing–publicly traded San Diego company announced earlier this year that first quarter revenues were up 900 percent from the same quarter last year
Our mission is to be the world’s premier cannabis and hemp industry innovators, leveraging our team of professionals to source, evaluate, invest in and purchase value-added sustainable companies, while allowing them to keep their integrity and entrepreneurial spirit. We strive to create awareness within our industry, pay homage to the visionaries and activists of the past and present, and provide the platform from which the industry can emerge into a global sustainable economy for all. Medical Marijuana Inc recognizes the vast and unequaled opportunities that exist in the rapidly expanding hemp and medical marijuana industries. The scientific recognition of cannabis has brought legalized marijuana use to the forefront of mainstream discussion, thus opening the door for safe and lucrative investment opportunities.
The company’s media relations office did not return a phone call seeking further information.
